Agreed Survivor regarding single target vs whole tumor lysate approach. But if Rindo had pushed out PFS for three months in a statsig way, the company would have had a “winner.”
I plan on making the case from a “theoretical” perspective in the future. I was going to end with “stay tuned” but was afraid people would start throwing things at me. I guess I did anyway! ;-)
News 
Market Data 
Discover 
